申请人:Abbott Laboratories
公开号:US06001849A1
公开(公告)日:1999-12-14
Novel heterocyclic ether compounds having the formula: ##STR1## wherein A, m, R, X, Y.sup.1, Y.sup.2 and Y.sup.3 are specifically defined, which are useful in selectively controlling chemical synaptic transmission; therapeutically-effective pharmaceutical compositions thereof; and use of said compositions to selectively control synaptic transmission in mammals.
具有以下结构的新型杂环醚化合物:##STR1## 其中A、m、R、X、Y.sup.1、Y.sup.2和Y.sup.3具体定义,可用于选择性控制化学突触传递;其治疗有效的药物组成物;以及利用该组成物在哺乳动物中选择性控制突触传递。